GlassScriptPhysician profile
Jose E Abreu Arbelo
NPI 1851656441
$23,084.91
in general payments reported to CMS, 2019-2025
59 companies · $4,710 in 2025
The $4,710 reported for 2025 was more than what 81% of Hematology & Oncology providers received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,994 · 2020: $1,315 · 2021: $1,550 · 2022: $4,212 · 2023: $4,647 · 2024: $4,658 · 2025: $4,710.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $14K · Education: $352.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $13,662.45 |
| Education | $351.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $1,964.84 | 2019-2025 | Erleada, Darzalex, Rybrevant |
| E.R. Squibb & Sons, L.L.C. | $1,862.70 | 2019-2025 | Opdivo, Reblozyl, Opdualag |
| Pbg Puerto Rico LLC | $1,739.53 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $1,302.24 | 2019-2025 | Lynparza, Enhertu, Tagrisso |
| Ge Healthcare | $1,284.40 | 2019 | |
| Merck Sharp & Dohme LLC | $1,107.63 | 2019-2025 | Keytruda, Keytruda Qlex, Welireg |
| Abbvie INC. | $1,031.86 | 2019-2025 | Venclexta, Epkinly |
| Eli Lilly Export S.A. Puerto Rico Branch | $940.72 | 2019-2025 | Verzenio, Jaypirca, Retevmo |
| Amgen INC. | $914.66 | 2019-2025 | Xgeva, Lumakras, Kyprolis |
| Novartis Pharmaceuticals Corporation | $891.35 | 2019-2025 | |
| Genentech USA, INC. | $872.41 | 2019-2025 | Polivy, Lunsumio, Columvi |
| Genzyme Corporation | $826.19 | 2020-2025 | |
| Alexion Pharmaceuticals, INC. | $689.58 | 2021-2025 | Ultomiris |
| Incyte Corporation | $659.45 | 2019-2025 | Jakafi, Monjuvi, Pemazyre |
| Eisai INC. | $518.33 | 2020-2025 |
Show all 59 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Puerto Rico INC. | $360.35 | 2023-2025 | Nubeqa, Vitrakvi, Stivarga |
| Puma Biotechnology, INC. | $336.96 | 2020-2025 | Nerlynx |
| Tempus Ai, INC | $325.31 | 2024-2025 | Xt Cdx |
| Sanofi-Aventis U.S. LLC | $316.54 | 2020-2024 | |
| Seagen INC. | $307.73 | 2021-2025 | Tukysa |
| Exelixis INC. | $290.39 | 2020-2025 | Cabometyx |
| Pfizer INC. | $288.60 | 2019-2025 | |
| Regeneron Healthcare Solutions, INC. | $278.36 | 2024-2025 | Libtayo, Lynozyfic |
| Taiho Oncology, INC. | $259.10 | 2019-2025 | |
| Astellas Pharma US INC | $237.59 | 2020-2025 | Xospata, Padcev |
| Janssen Biotech, INC. | $198.99 | 2020-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $197.05 | 2020-2022 | |
| Rigel Pharmaceuticals, INC. | $194.15 | 2021-2025 | Rezlidhia, Tavalisse, Gavreto |
| Beigene USA, INC. | $190.72 | 2020-2024 | Brukinsa |
| Springworks Therapeutics, INC. | $189.83 | 2024-2025 | Ogsiveo |
| Gilead Sciences, INC. | $183.58 | 2022-2025 | Trodelvy |
| Sobi, INC | $173.18 | 2023-2025 | |
| Adc Therapeutics America, INC. | $170.60 | 2021-2023 | |
| Blueprint Medicines Corporation | $145.12 | 2023-2024 | Ayvakit |
| Cti Biopharma Corp. | $145.06 | 2023 | Vonjo |
| Array Biopharma INC | $138.98 | 2022-2025 | Mektovi, Braftovi, Lorbrena |
| Verity Pharmaceuticals INC. | $122.15 | 2022-2024 | Trelstar, Akynzeo |
| Mirati Therapeutics, INC. | $120.00 | 2023-2024 | Krazati |
| Adaptive Biotechnologies Corporation | $117.34 | 2022-2024 | Clonoseq |
| Genmab U.S., INC. | $112.72 | 2024-2025 | Epkinly |
| Morphosys, US INC. | $112.45 | 2021-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $104.80 | 2019-2021 | |
| Lilly USA, LLC | $97.49 | 2023 | |
| Partner Therapeutics, INC. | $93.73 | 2020 | |
| Jazz Pharmaceuticals INC. | $89.68 | 2021-2025 | |
| Stemline Therapeutics INC. | $88.05 | 2024-2025 | Orserdu |
| Beone Medicines USA, INC. | $87.79 | 2025 | Brukinsa |
| Caris Mpi, INC. | $75.73 | 2025 | Mi Cancer Seek |
| Kyowa Kirin, INC. | $50.00 | 2021-2023 | Poteligeo |
| Tolmar, INC. | $44.17 | 2025 | Rubraca, Eligard |
| Pharmaand Gmbh | $44.17 | 2025 | Rubraca |
| Ipsen Biopharmaceuticals, INC | $42.08 | 2020-2024 | Somatuline Depot, Onivyde |
| Emd Serono, INC. | $30.90 | 2023-2024 | Bavencio |
| Teva Pharmaceuticals USA, INC. | $25.00 | 2022 | |
| Pharmaessentia USA Corporation | $21.96 | 2022 | |
| Syndax Pharmaceuticals, INC. | $19.05 | 2025 | |
| Sun Pharmaceutical Industries INC. | $17.33 | 2025 | |
| Clovis Oncology, INC. | $17.29 | 2022 | |
| Deciphera Pharmaceuticals INC. | $16.95 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jose Abreu Arbelo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.